Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 25 June, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Ortin Laboratories Ltd

About the Company - Ortin Laboratories Ltd

Ortin Laboratories Ltd. is a Public Limited Listed company incorporated on 27/10/1986 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24110TG1986PLC006885 and registration number is 006885. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 8.23 Cr. and Equity Capital is Rs. 8.13 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
PharmaceuticalsD. No. 1-8-B4, Ground Floor, F3 HIG, Block-4, Street No.3, Hyderabad Telangana 500044info@ortinlabsindia.com
http://www.ortinlabsindia.com
Management
NamePosition Held
Mr. Murali Krishna RayaproluChairman & Ind.Director
Mr. S Murali Krishna MurthyManaging Director
Mr. S Srinivas KumarWhole Time Director
Mr. S Balaji VenkateswarluNon Executive Director
Mr. B Gopal ReddyIndependent Director
Ms. Pottur SujathaIndependent Director

Basic Stock Data of Ortin Laboratories Ltd

Last Updated: June 21, 2024, 10:37 pm

Market Cap 16.8 Cr.
Current Price 20.6
High / Low26.4/16.2
Stock P/E
Book Value 3.47
Dividend Yield0.00 %
ROCE60.2 %
ROE118 %
Face Value 10.0
PEG Ratio0.00

Competitors of Ortin Laboratories Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Ajanta Pharma Ltd 29,316 Cr. 2,3312,540/1,37836.3 2831.54 %31.6 %23.2 % 2.00
Wockhardt Ltd 9,519 Cr. 620630/213 2190.00 %0.83 %12.1 % 5.00
Cipla Ltd 1,21,181 Cr. 1,5001,582/99628.5 3310.57 %23.1 %17.0 % 2.00
Biofil Chemicals & Pharmaceuticals Ltd 99.4 Cr. 61.179.0/42.2140 11.20.00 %4.94 %4.00 % 10.0
Lyka Labs Ltd 359 Cr. 109144/97.9 20.60.00 %3.78 %6.32 % 10.0
Industry Average15,514.85 Cr1,232.6438.85198.330.36%16.81%15.50%6.46

Ortin Laboratories Ltd Quarterly Results

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales51.771.761.982.291.662.452.620.791.171.491.570.270.14
Expenses49.611.551.612.001.652.592.411.010.551.521.391.172.74
Operating Profit2.160.210.370.290.01-0.140.21-0.220.62-0.030.18-0.90-2.60
OPM %4.17%11.93%18.69%12.66%0.60%-5.71%8.02%-27.85%52.99%-2.01%11.46%-333.33%-1,857.14%
Other Income0.120.050.000.040.000.000.000.000.000.000.000.000.00
Interest0.860.190.180.190.190.240.100.090.100.120.110.150.14
Depreciation0.530.070.070.07-0.070.230.070.070.070.030.060.060.06
Profit before tax0.890.000.120.07-0.11-0.610.04-0.380.45-0.180.01-1.11-2.80
Tax %32.58%25.00%28.57%18.18%24.59%1,150.00%121.05%0.00%5.56%0.00%-1.80%0.71%
Net Profit0.600.800.090.05-0.09-0.45-0.430.080.46-0.180.02-1.12-2.79
EPS in Rs0.360.980.110.06-0.11-0.55-0.530.100.57-0.220.02-1.38-3.43

Last Updated: May 10, 2024, 2:46 pm

Ortin Laboratories Ltd Quarterly Chart

Ortin Laboratories Ltd Profit & Loss

Last Updated: May 27, 2024, 5:52 am

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales90.4674.7467.0060.2962.7261.5779.63167.51197.368.168.236.003.47
Expenses83.5368.1760.9053.8056.8356.1274.22160.83191.666.927.855.476.82
Operating Profit6.936.576.106.495.895.455.416.685.701.240.380.53-3.35
OPM %7.66%8.79%9.10%10.76%9.39%8.85%6.79%3.99%2.89%15.20%4.62%8.83%-96.54%
Other Income0.260.240.810.000.570.320.450.130.180.050.190.010.00
Interest3.283.553.723.523.422.943.493.223.210.870.810.400.52
Depreciation1.331.401.511.641.651.701.691.751.960.290.290.250.21
Profit before tax2.581.861.681.331.391.130.681.840.710.13-0.53-0.11-4.08
Tax %50.78%41.40%29.17%32.33%41.01%55.75%0.00%30.43%181.69%-623.08%24.53%18.18%
Net Profit1.281.091.190.900.830.500.681.28-0.560.95-0.40-0.09-4.07
EPS in Rs0.760.640.700.530.490.300.400.76-0.331.17-0.49-0.11-5.01
Dividend Payout %66.17%38.85%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Ortin Laboratories Ltd Profit & Loss Yearly Chart

Ortin Laboratories Ltd Growth

Compounded Sales Growth
10 Years:-29%
5 Years:-58%
3 Years:-35%
TTM:-62%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:-11386%
Stock Price CAGR
10 Years:%
5 Years:8%
3 Years:-15%
1 Year:-9%
Return on Equity
10 Years:-2%
5 Years:-11%
3 Years:-29%
Last Year:-118%

Last Updated: June 21, 2024, 5:07 pm

Ortin Laboratories Ltd Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital16.9416.9416.9416.9416.9416.9416.9416.9416.948.138.138.138.13
Reserves3.243.845.025.506.336.467.148.156.883.222.832.731.63
Borrowings13.0817.9218.6820.9620.8517.3417.3419.4719.576.946.146.456.01
Other Liabilities49.8034.8031.9323.8721.2220.7932.2460.5373.132.973.613.892.46
Total Liabilities83.0673.5072.5767.2765.3461.5373.66105.09116.5221.2620.7121.2018.23
Fixed Assets23.8524.7723.9021.8321.6320.6920.0321.2922.4514.3814.2113.9613.84
CWIP0.000.000.000.000.000.350.400.530.430.430.430.430.43
Investments0.030.030.030.030.030.070.080.080.070.000.000.000.00
Other Assets59.1848.7048.6445.4143.6840.4253.1583.1993.576.456.076.813.96
Total Assets83.0673.5072.5767.2765.3461.5373.66105.09116.5221.2620.7121.2018.23

Ortin Laboratories Ltd Reserves and Borrowings Chart

Ortin Laboratories Ltd Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 0.29-1.66-1.76-1.380.521.941.566.523.3018.032.15-0.25
Cash from Investing Activity -2.23-2.08-0.020.22-0.86-1.26-0.90-3.27-3.090.07-0.130.01
Cash from Financing Activity 1.794.700.971.730.27-0.820.07-2.89-1.33-9.86-0.470.90
Net Cash Flow-0.150.96-0.810.58-0.07-0.140.730.37-1.128.251.550.66

Ortin Laboratories Ltd Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days176.97134.10116.69103.7753.1390.35100.1582.4368.71174.90143.69208.05
Inventory Days60.92102.80162.92192.30148.72158.21152.21100.07117.80169.10136.29279.94
Days Payable250.38199.45197.95151.0924.82108.10143.09145.12155.80123.8261.88166.89
Cash Conversion Cycle-12.5037.4581.66144.97177.04140.45109.2837.3830.70220.17218.10321.10
Working Capital Days35.5556.9486.07118.60104.81126.92108.6848.9438.38158.7986.93168.51
ROCE %22.50%14.90%13.08%12.07%10.92%9.57%9.44%11.77%8.94%3.24%1.58%1.80%

Ortin Laboratories Ltd Financial Efficiency Indicators Chart

Ortin Laboratories Ltd Share Holding Pattern

MonthJun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
Promoters15.68%15.68%15.68%15.68%15.68%15.68%15.68%21.51%7.36%7.37%7.36%1.23%
Public84.32%84.32%84.32%84.32%84.32%84.32%84.31%78.49%92.63%92.64%92.64%98.76%
No. of Shareholders12,30211,94712,81912,66212,57112,44912,78112,58512,18111,83612,31412,192

Ortin Laboratories Ltd Shareholding Pattern Chart

No. of Ortin Laboratories Ltd Shareholders

This stock is not held by any mutual fund

Ortin Laboratories Ltd ROCE Trend

Ortin Laboratories Ltd EPS Trend

Ortin Laboratories Ltd Key Financial Ratios

MonthMar 12
FaceValue10.00
Basic EPS (Rs.)2.73
Diluted EPS (Rs.)2.73
Cash EPS (Rs.)3.59
Book Value[Excl.RevalReserv]/Share (Rs.)14.47
Book Value[Incl.RevalReserv]/Share (Rs.)14.47
Revenue From Operations / Share (Rs.)50.63
PBDIT / Share (Rs.)6.99
PBIT / Share (Rs.)6.13
PBT / Share (Rs.)4.20
Net Profit / Share (Rs.)2.73
NP After MI And SOA / Share (Rs.)2.73
PBDIT Margin (%)13.81
PBIT Margin (%)12.10
PBT Margin (%)8.30
Net Profit Margin (%)5.38
NP After MI And SOA Margin (%)5.38
Return on Networth / Equity (%)18.85
Return on Capital Employeed (%)34.77
Return On Assets (%)5.67
Long Term Debt / Equity (X)0.11
Total Debt / Equity (X)0.58
Current Ratio (X)1.11
Quick Ratio (X)0.82
Interest Coverage Ratio (X)3.63
Interest Coverage Ratio (Post Tax) (X)2.42
Enterprise Value (Cr.)62.39
EV / Net Operating Revenue (X)0.72
EV / EBITDA (X)5.27
MarketCap / Net Operating Revenue (X)0.56
Price / BV (X)1.97
Price / Net Operating Revenue (X)0.56
EarningsYield0.09

Ortin Laboratories Ltd Profitability Ratios (%)

Ortin Laboratories Ltd Liquidity Ratios

Ortin Laboratories Ltd Liquidity Ratios (%)

Ortin Laboratories Ltd Interest Coverage Ratios (%)

Ortin Laboratories Ltd Valuation Ratios

Fair Value

Fair Value: 62.65

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

Undervalued: 204.11% compared to the current price 20.6

Default values used*: Deafault value of 15 for Stock P/E is used

Intrinsic Value: 44.26

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators along with EPS growth.

Undervalued: 114.87% compared to the current price ₹20.6

Default values used*: Deafault value of 15 for Stock P/E is used

Last 5 Year EPS CAGR: -29.35%

*Investments are subject to market risks

Strength and Weakness of Ortin Laboratories Ltd

StrengthWeakness
  1. The company has shown consistent growth in sales (68.24 cr) and profit (0.66 cr) over the years.
  1. The stock has a low average ROCE of 9.98%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 94.93, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 125.48, which may not be favorable.
  4. The company has higher borrowings (14.67) compared to reserves (4.84), which may suggest financial risk.

Should I Buy Ortin Laboratories Ltd?

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ortin Laboratories Ltd:
    1. Net Profit Margin: 5.38%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 34.77% (Industry Average ROCE: %)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 18.85% (Industry Average ROE: %)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 2.42
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.82
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. ✗ Stock P/E: (Industry average Stock P/E: )
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.58
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

FAQ

What is the latest fair value of Ortin Laboratories Ltd?

The latest fair value of Ortin Laboratories Ltd is ₹62.65.

What is the Market Cap of Ortin Laboratories Ltd?

The Market Cap of Ortin Laboratories Ltd is 16.8 Cr..

What is the current Stock Price of Ortin Laboratories Ltd as on 23 June 2024?

The current stock price of Ortin Laboratories Ltd as on 23 June 2024 is ₹20.6.

What is the High / Low of Ortin Laboratories Ltd stocks in FY 2024?

In FY 2024, the High / Low of Ortin Laboratories Ltd stocks is 26.4/16.2.

What is the Stock P/E of Ortin Laboratories Ltd?

The Stock P/E of Ortin Laboratories Ltd is .

What is the Book Value of Ortin Laboratories Ltd?

The Book Value of Ortin Laboratories Ltd is 3.47.

What is the Dividend Yield of Ortin Laboratories Ltd?

The Dividend Yield of Ortin Laboratories Ltd is 0.00 %.

What is the ROCE of Ortin Laboratories Ltd?

The ROCE of Ortin Laboratories Ltd is 60.2 %.

What is the ROE of Ortin Laboratories Ltd?

The ROE of Ortin Laboratories Ltd is 118 %.

What is the Face Value of Ortin Laboratories Ltd?

The Face Value of Ortin Laboratories Ltd is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Ortin Laboratories Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE